New drug aims to tame stubborn high blood pressure
Disease control
Recruiting now
This study tests a new drug called RTN-001 for people whose high blood pressure is not controlled by at least two other medications. About 280 adults will take either RTN-001 or a placebo daily for 12 weeks. The main goal is to see if RTN-001 lowers blood pressure more than a pla…
Phase: PHASE2 • Sponsor: Retension Pharmaceuticals. Inc. • Aim: Disease control
Last updated May 17, 2026 04:11 UTC